Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 179,640 | 147,106 | 162,051 | 136,325 | 89,426 |
| Marketable Securities | 47,578 | 45,553 | 44,887 | 47,300 | 11,409 |
| Receivables | 17,563 | 9,487 | 2,367 | 1,241 | 4,878 |
| Inventories | 18,843 | 9,964 | N/A | N/A | N/A |
| TOTAL | $273,906 | $217,496 | $213,915 | $186,726 | $106,815 |
| Non-Current Assets | |||||
| PPE Net | 13,755 | 13,028 | 3,854 | 2,476 | 2,447 |
| Investments And Advances | 4,281 | 4,953 | 5,341 | 5,161 | 1,415 |
| Intangibles | 8,558 | 8,807 | 372 | 0 | 0 |
| Other Non-Current Assets | 28,460 | 25,646 | 16,286 | 438 | 1,310 |
| TOTAL | $55,054 | $52,434 | $25,852 | $8,074 | $5,171 |
| Total Assets | $328,960 | $269,931 | $239,767 | $194,800 | $111,987 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,271 | 10,783 | 8,624 | 5,134 | 4,470 |
| Other current liabilities | 32,111 | 28,683 | 10,949 | 11,769 | 7,042 |
| TOTAL | $53,190 | $54,426 | $29,251 | $16,903 | $11,512 |
| Non-Current Liabilities | |||||
| Long Term Debt | 103,082 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 8,438 | 8,148 | 8,432 | N/A | N/A |
| Other Non-Current Liabilities | 22,760 | 20,344 | 11,702 | 0 | 20,201 |
| TOTAL | $128,157 | $27,174 | $24,240 | $N/A | $20,201 |
| Total Liabilities | $181,346 | $81,600 | $53,491 | $16,903 | $31,712 |
| Shareholders' Equity | |||||
| Common Shares | 6,942 | 6,097 | 5,405 | 4,877 | 4,671 |
| Retained earnings | -526,367 | -350,867 | -216,384 | -148,993 | -221,999 |
| Other shareholders' equity | 1,814 | 1,375 | 0 | 0 | 0 |
| TOTAL | $147,614 | $188,330 | $186,277 | $168,999 | $80,274 |
| Total Liabilities And Equity | $328,960 | $269,931 | $239,767 | $185,902 | $111,987 |